H. Lundbeck A/S | Balance Sheet

Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,859
3,669
1,521
2,217
3,677
6,635
Total Accounts Receivable
3,364
3,521
3,762
3,600
3,641
3,116
Inventories
1,893
1,991
2,217
1,528
1,376
1,753
Other Current Assets
247
205
160
179
150
145
Total Current Assets
11,363
9,386
7,660
7,524
8,844
11,649
Net Property, Plant & Equipment
2,778
2,724
2,246
2,162
1,990
2,018
Total Investments and Advances
60
71
68
48
67
70
Long-Term Note Receivable
82
50
56
72
76
86
Intangible Assets
9,077
12,670
9,794
8,839
7,565
8,023
Total Assets
23,649
25,637
21,749
20,210
19,975
23,435
ST Debt & Current Portion LT Debt
19
84
83
188
-
Accounts Payable
1,967
4,930
4,349
3,650
3,203
Income Tax Payable
58
49
71
157
54
Other Current Liabilities
4,474
2,139
3,245
3,781
3,222
Total Current Liabilities
6,518
7,202
7,748
7,776
6,479
Long-Term Debt
2,141
3,259
3,687
1,685
-
Provision for Risks & Charges
377
457
613
484
524
Deferred Taxes
843
457
1,009
1,017
699
Other Liabilities
-
-
-
23
57
Total Liabilities
10,168
12,111
12,964
10,516
7,794
Common Equity (Total)
13,481
13,526
8,785
9,694
12,181
Total Shareholders' Equity
13,481
13,526
8,785
9,694
12,181
Total Equity
13,481
13,526
8,785
9,694
12,181
Liabilities & Shareholders' Equity
23,649
25,637
21,749
20,210
19,975

About H. Lundbeck A/S

View Profile
Address
Ottiliavej 9
Valby CR 2500
Denmark
Employees -
Website http://www.lundbeck.com
Updated 07/08/2019
H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.